Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Patrick T. McGann, MD, MS
Researcher Director
Pediatric and Adult Sickle Cell
and Hemoglobinopathy Program
Hasbro Children's Hospital
593 Eddy Street, Suite 105
Providence, Rhode Island, United States
Patrick T. McGann, MD, is the Director of the new combined pediatric and adult sickle cell and hemoglobinopathy program at Rhode Island Hospital and its Hasbro Children’s Hospital. He is also a pediatric hematologist within the Pediatric Hematology/Oncology Program at Hasbro Children’s Hospital.
Dr. McGann is an international sickle cell expert with a focus on improving the lives of individuals with sickle cell disease. Prior to joining the Lifespan team, he spent 8 years as a pediatric hematologist and sickle cell specialist at Cincinnati Children’s Hospital Medical Center. In addition to his clinical and research work in the United States, Dr. McGann does extensive work to address the global burden of sickle cell disease, particularly in the Republic of Angola, where he has worked for over 10 years.
Dr. McGann has focused his extensive academic research on improving outcomes for children with sickle cell anemia throughout the United States and across the world. He has been the principal investigator on numerous research projects funded by the National Heart, Lung, and Blood Institute, the Doris Duke Charitable Foundation, and the American Society of Hematology.
Representative Publications:
Time to Invest in Sickle Cell Anemia as a Global Health Priority
Hydroxyurea therapy for sickle cell anemia
Related Content
-
Oswaldo L. Castro, MDDr. Oswaldo Castro is Professor Emeritus...
-
Gregory J. Kato, MDDr. Kato is a hematologist with an activ...
-
Sickle Cell Disease Association of America – Mobile Chapter, Inc.The Sickle Cell Disease Association of A...
-
Texas Children’s HospitalThe Sickle Cell Center at Texas Children...
-
Patient-reported experience measure in sickle cell diseaseObjectives: To develop patient-reported...
-
Vanderbilt University Medical CenterThe Vanderbilt-Meharry-Matthew Walker Ce...
-
Gene-Therapy Company Crispr Drops as FDA Puts Trial on HoldCrispr Therapeutics AG plunged after the...